PTGX (PTGX) Stock Price & Analysis
PTGX (PTGX) fell 2.07% to USD 145.72 as of September 8, 2026 at 10:16 UTC, according to Nexqual real-time market data.
PTGX last closed at USD 145.72; the session ranged USD 144.13–147.99 on volume of 501,305 shares. Market capitalization is —, with a 52-week range of USD 54.5–160.81 (NGM). Source: Nexqual, September 8, 2026 at 10:16 UTC.
Key Statistics (as of September 8, 2026 at 10:16 UTC)
| Price | USD 145.72 |
|---|---|
| Change | ▼ 2.07% (down) |
| Previous Close | USD 145.72 |
| Open | USD 145.72 |
| Day Range | USD 144.13 – 147.99 |
| 52-Week Range | USD 54.5 – 160.81 |
| Volume | 501,305 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (PTGX)
Nexqual's technical model rates PTGX "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 10:16 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.74 (neutral) |
| vs SMA50 | Above (USD 141) |
| MACD | 1.86 (positive) |
From PTGX's Latest SEC 10-K Filing (filed 2026-02-25)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals, Inc. | USD 20.56 | ▼ 1.06% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 102.74 | ▼ 2.54% |
| XENE | Xenon Pharmaceuticals Inc. | USD 59.75 | ▼ 0.68% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| IDYA | IDEAYA Biosciences, Inc. | USD 39.86 | ▼ 0.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:16 UTC. This page is informational and not investment advice.